Combined assessment of DYRK1A, BDNF and homocysteine levels as diagnostic marker for Alzheimer’s disease

Early identification of Alzheimer’s disease (AD) risk factors would aid development of interventions to delay the onset of dementia, but current biomarkers are invasive and/or costly to assess. Validated plasma biomarkers would circumvent these challenges. We previously identified the kinase DYRK1A...

Descripción completa

Detalles Bibliográficos
Autores principales: Janel, N, Alexopoulos, P, Badel, A, Lamari, F, Camproux, A C, Lagarde, J, Simon, S, Feraudet-Tarisse, C, Lamourette, P, Arbones, M, Paul, J L, Dubois, B, Potier, M C, Sarazin, M, Delabar, J M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537644/
https://www.ncbi.nlm.nih.gov/pubmed/28632203
http://dx.doi.org/10.1038/tp.2017.123

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5537644/
https://www.ncbi.nlm.nih.gov/pubmed/28632203
http://dx.doi.org/10.1038/tp.2017.123

Ejemplares similares